Intriguingly, XPO1 expression is markedly increased in a wide array of tumour cells, including osteosarcoma, glioma, lung cancer, ovarian cancer, pancreatic cancer, oesophageal cancer, gastric cancer and colorectal cancer (CRC) cells. This evidence concerns the gene XPO1 and colorectal carcinoma.